Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival …
K Swedberg, P Held, J Kjekshus… - … England Journal of …, 1992 - Mass Medical Soc
Background. Long-term administration of angiotensin-converting—enzyme (ACE) inhibitors
has been shown to improve survival in patients with symptomatic left ventricular failure and …
has been shown to improve survival in patients with symptomatic left ventricular failure and …
[引用][C] Early and late angiotensin-converting enzyme inhibition after myocardial infarction: an overview of randomized clinical trials
E Ambrosioni, C Borghi - The American journal of medicine, 2003 - amjmed.com
An association between the activation of the renin-angiotensin-aldosterone system and the
development of atherosclerotic disease and its complications has been demonstrated in …
development of atherosclerotic disease and its complications has been demonstrated in …
Cardiovascular protection by angiotensin-converting enzyme inhibition
R Ferrari - European Heart Journal Supplements, 2009 - academic.oup.com
One of the most important health achievements during the twentieth century was the
unravelling of the causes of the cardiovascular diseases (CVDs). Since the 1980s, coronary …
unravelling of the causes of the cardiovascular diseases (CVDs). Since the 1980s, coronary …
Angiotensin receptor blockers reduce cardiovascular events, including the risk of myocardial infarction
FH Messerli, S Bangalore - Circulation, 2017 - Am Heart Assoc
Angiotensin Receptor Blockers Reduce Cardiovascular Events, Including the Risk of
Myocardial Infarction | Circulation Science Volunteer Warning signs SearchSearch …
Myocardial Infarction | Circulation Science Volunteer Warning signs SearchSearch …
Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials
Objectives To evaluate the cardiovascular outcomes and other outcomes associated with
angiotensin receptor blockers. Design Systematic review of randomised controlled trials with …
angiotensin receptor blockers. Design Systematic review of randomised controlled trials with …
Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease
J Martin, H Krum - Pharmacological research, 2002 - Elsevier
Blockade of the renin–angiotensin system by angiotensin converting enzyme (ACE)
inhibitors reduces mortality and morbidity in patients post-myocardial infarction as well as in …
inhibitors reduces mortality and morbidity in patients post-myocardial infarction as well as in …
[引用][C] Angiotensin receptor blockers and ACE inhibitors are similarly effective in chronic heart failure and in high-risk acute myocardial infarction. Commentary.
DS Roffman - Evidence-based Cardiovascular Medicine, 2005 - europepmc.org
Angiotensin receptor blockers and ACE inhibitors are similarly effective in chronic heart failure
and in high-risk acute myocardial infarction. Commentary. - Abstract - Europe PMC Sign in …
and in high-risk acute myocardial infarction. Commentary. - Abstract - Europe PMC Sign in …
An economic evaluation of valsartan for post-MI patients in the UK who are not suitable for treatment with ACE inhibitors
M Taylor, PA Scuffham, S Chaplin, NL Papo - Value in health, 2009 - Elsevier
OBJECTIVES: The overall objective of this study was to estimate the costs and outcomes
associated with treatment with valsartan for post-myocardial infarction (post-MI) patients with …
associated with treatment with valsartan for post-myocardial infarction (post-MI) patients with …
Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis
GLO Salvador, VM Marmentini… - European Journal of …, 2017 - academic.oup.com
Background There are few reviews comparing the long-term outcomes of the use of
angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in a …
angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in a …
The benefits of sacubitril–valsartan in patients with acute myocardial infarction: a systematic review and meta‐analysis
B Xiong, D Nie, J Qian, Y Yao, G Yang… - ESC heart …, 2021 - Wiley Online Library
Aims We aimed to investigate whether sacubitril–valsartan could further improve the
prognosis, cardiac function, and left ventricular (LV) remodelling in patients following acute …
prognosis, cardiac function, and left ventricular (LV) remodelling in patients following acute …